PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27419352-0	2001	Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSF.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	60-65	
18528228-0	2008	Methimazole-induced severe febrile neutropenia responding to recombinant human granulocyte colony stimulating factor.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	79-116	
16553037-0	2006	Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.	Methimazole	24-35	colony stimulating factor 3	Homo sapiens	90-127	
27419352-4	2001	We think that in patients with methimazole-induced agranulocytosis, G-CSF may reduce the risk and severity of infection and in some cases should be accepted as a part of the standard therapy.	Methimazole	31-42	colony stimulating factor 3	Homo sapiens	68-73	
15251798-0	1997	Recombinant human granulocyte colony-stimulating factor in treatment of methimazole-induced agranulocytosis.	Methimazole	72-83	colony stimulating factor 3	Homo sapiens	18-55	
9803142-5	1998	In the second case we report the use of granulocyte colony-stimulating factor (G-CSF) for treatment of a patient with methimazole-induced granulocytopenia.	Methimazole	118-129	colony stimulating factor 3	Homo sapiens	40-77	
9803142-5	1998	In the second case we report the use of granulocyte colony-stimulating factor (G-CSF) for treatment of a patient with methimazole-induced granulocytopenia.	Methimazole	118-129	colony stimulating factor 3	Homo sapiens	79-84	
9777751-0	1998	Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	99-136	
15251798-1	1997	OBJECTIVE: To describe a patient with methimazole-induced agranulocytosis who was treated with recombinant human granulocyte colony-stimulating factor (G-CSF).	Methimazole	38-49	colony stimulating factor 3	Homo sapiens	113-150	
15251798-1	1997	OBJECTIVE: To describe a patient with methimazole-induced agranulocytosis who was treated with recombinant human granulocyte colony-stimulating factor (G-CSF).	Methimazole	38-49	colony stimulating factor 3	Homo sapiens	152-157	
7542790-0	1995	Methimazole agranulocytosis treated with recombinant human granulocyte colony stimulating factor.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	59-96	
8605651-0	1995	Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	67-104	
7522068-6	1994	Since agranulocytosis is considered to be a severe and fatal complication of methimazole therapy, treatment with granulocyte colony stimulating factor seems to be useful for this life-threatening condition.	Methimazole	77-88	colony stimulating factor 3	Homo sapiens	113-150	
7530522-0	1994	Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	67-104	
7530522-0	1994	Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	106-111	
7521347-0	1993	Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).	Methimazole	13-24	colony stimulating factor 3	Homo sapiens	73-110	
27408395-0	2016	Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	72-109	
1281122-0	1992	[Change in serum G-CSF levels in patients with Graves" disease by treatment with methimazole].	Methimazole	81-92	colony stimulating factor 3	Homo sapiens	17-22	
1281122-1	1992	We evaluated the determination of serum G-CSF in the diagnosis of granulocytopenia due to methimazole (MMI) in 54 patients with Graves" disease, while they were being treated with MMI, by way of measuring WBC counts and serum levels of G-CSF, thyroid hormones, IgE, and interleukin-2.	Methimazole	90-101	colony stimulating factor 3	Homo sapiens	40-45	
2672934-0	1989	Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	40-77	
29026576-0	2017	Use of granulocyte colony-stimulating factor in the treatment of methimazole-induced agranulocytosis: a case report.	Methimazole	65-76	colony stimulating factor 3	Homo sapiens	7-44	
27408395-0	2016	Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics.	Methimazole	0-11	colony stimulating factor 3	Homo sapiens	111-116